Safety, Tolerability and Pharmacokinetics of TPOXX When Administered Orally for 28 Days
Study sponsor: SIGA Technologies
Primary completion is the date data collection ends for the main study measures, not when results are published.
Primary completion2023-05-12Actual
Enrollment · participants467Actual
Source updated2026-09-11Last update listed in the registry record
No recorded changes are available for this view and time period. Our history may be incomplete; this does not establish that the trial stayed unchanged.